Investor event will feature Q&A on SCS market and Nuvectra’s Algovita system
PLANO, Texas, March 27, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Cowen and Company and The Ruth Group are hosting a physician panel on the spinal cord stimulation market and the Algovita system. The event will feature discussions with Jeffery Rowe, MD, and Brian Bannister, MD, and will be moderated by Cowen medical technology analyst Josh Jennings, MD.
||Spinal Cord Stimulation Physician Panel
||Wednesday, March 29, 2017
||12:00 pm ET
||Cowen and Company Offices; 599 Lexington Ave, New York
A webcast of the event will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com.
If interested in attending the live event please contact your Cowen sales representative or The Ruth Group.
Jeffery Rowe, MD is a practicing physician at Main Line Spine in King of Prussia Pennsylvania, a comprehensive care center for spine related conditions and injuries. Dr. Rowe attended medical school at Saba University School of Medicine. Upon completing medical school he entered a General Surgery residency at Medical College of Pennsylvania/Hahnemann University before beginning his Physical Medicine and Rehabilitation residency at University of Pennsylvania. Following residency he was fellowship trained in Interventional Spine and Pain Medicine. Dr. Rowe is board certified in Physical Medicine & Rehabilitation and in Pain Medicine. His professional interests include the management of complex pain related medical issues with minimally invasive injections through trial and surgically implanted spinal cord stimulators.
Brian Bannister, MD is a practicing physician at Progressive Pain Management in Monmouth County, NJ, where he takes a multimodal approaches to pain control using proven, innovative techniques, combined with compassionate and individualized care. Dr. Bannister attended medical school at the State University of New York, Upstate Medical University where he also completed a Fellowship in Pain Management and his residency in Clinical Anesthesiology. Dr. Bannister is board certified in Anesthesiology.
About Nuvectra Corporation
Nuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.
Walter Berger, Chief Operating Officer and Chief Financial Officer
Jennifer Armstrong, Media Relations
The Ruth Group